CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in GILD — Gilead Sciences, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,030,338,200
-$109,956,478 QoQ
Shares Held
8,155,281
-0.3% QoQ
Ownership
0.658%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#24
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $34,394,076,697 across 15 Drug Manufacturers - General names. GILD ranks #8 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,001,955 | $7,198,925,485 | |
| 2 | MRK |
Merck & Co., Inc.
|
54,365,289 | $6,985,939,635 | |
| 3 | AMGN |
Amgen Inc
|
15,034,038 | $5,444,125,839 | |
| 4 | JNJ |
Johnson & Johnson
|
19,126,165 | $4,857,472,124 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
67,595,177 | $3,894,834,098 | |
| 6 | ABBV |
AbbVie Inc.
|
12,914,230 | $3,249,736,836 | |
| 7 | PFE |
Pfizer Inc
|
52,548,228 | $1,265,361,329 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
8,155,281 | $1,030,338,200 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,030,338,200 | 8,155,281 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $1,140,294,678 | 8,181,780 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $982,753,404 | 8,006,790 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $880,325,460 | 7,930,860 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $886,968,204 | 8,000,074 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $897,576,637 | 8,010,501 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $739,216,696 | 8,002,779 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $650,009,424 | 7,752,975 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $516,497,109 | 7,528,015 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $539,651,795 | 7,367,260 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $589,873,423 | 7,281,489 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $539,118,884 | 7,194,007 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $558,927,439 | 7,252,205 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $614,114,817 | 7,401,649 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $648,092,724 | 7,549,129 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $457,885,820 | 7,422,367 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $440,130,281 | 7,120,697 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $431,097,632 | 7,251,432 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $524,971,026 | 7,230,010 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $493,234,319 | 7,061,336 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $478,420,756 | 6,947,731 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $414,251,026 | 6,409,578 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $380,699,096 | 6,534,485 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $411,718,173 | 6,515,559 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $531,371,799 | 6,906,314 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $532,811,454 | 7,126,959 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||